FDA OK's first Plavix generics
This article was originally published in Scrip
Executive Summary
A string of drug makers on 17 May won the US FDA's blessing to market generic versions of Bristol-Myers Squibb's and Sanofi's blood-thinning agent Plavix (clopidogrel bisulfate), which lost patent protection on the same day (scripintelligence, 17 May 2012 ).